Arbutus Biopharma Corp

:ABUS

4.78

-0.01 (-0.21%)

4:18:00 PM EDT: $4.71 -0.07 (-1.46%)

Market Cap (Intraday)	917.38M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.61 Million
Adjusted EPS	-$0.04

See more estimates

10-Day MA	$4.67
50-Day MA	$4.52
200-Day MA	$3.78

See more pivots

Arbutus Biopharma Corp Stock, :ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.